Streetbeat News

Products Services

MCRB

Seres Therapeutics reported preliminary unaudited net sales of $10.4M for Q4 2023, with total net sales of $19.6M since the June 2023 launch of Vowst. The sales figures reflect a gross-to-net reduction of 13%. The company saw significant adoption of Vowst, with 2,833 patient enrollment forms received and 2,015 new patient starts by the end of 2023.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 12:11 pm

CYN

Cyngn Inc. has been granted its 18th US patent, US-11,837,090-B2, for adaptive traffic rule-based decision making in autonomous driving. This technology is designed to optimize driving decisions for autonomous vehicles when faced with multiple environmental rules or constraints.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 12:09 pm

LASE

Laser Photonics Corporation (NASDAQ:LASE), a developer of CleanTech laser systems, has received an order from Laserweld Inc. for its LPC-1500-CTHD laser blasting system. The financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 12:06 pm

F

RIVN

TSLA

Tesla Inc.'s (NASDAQ:TSLA) price cuts in 2023 have significantly reduced the price gap between electric vehicles (EVs) and internal combustion engine (ICE) vehicles. Cox Automotive reports that by December, the average Tesla vehicle price was $50,051, close to the average ICE vehicle price of $48,759. The average EV price also dropped to $50,798. High inventory levels for EVs were reported, but Tesla and Rivian Automotive Inc. (NASDAQ:RIVN) were excluded from this data. The University of Exeter suggests EVs may become more affordable than gas vehicles in the U.S. this year. Ford Motor Co (NYSE:F) paused its $12 billion EV funding due to high EV costs and customer reluctance.

Portfolio Pulse from Ramakrishnan M

January 09, 2024 | 12:04 pm

MDWD

MediWound announced that the FDA has accepted for review the supplement to the NexoBrid Biologics License Application (BLA) to include treatment for pediatric patients with severe thermal burns. This acceptance could potentially expand the use of NexoBrid to a broader patient population.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 12:03 pm

EXK

Endeavour Silver Corp. reported its full year 2023 production, totaling 5.7 million ounces of silver and 37,858 ounces of gold, which equates to 8.7 million silver equivalent ounces. The fourth quarter contributed 1.4 million ounces of silver and 9,440 ounces of gold to this total.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:55 am

GMAB

PFE

The FDA has accepted a priority review for Genmab and Pfizer's supplemental Biologics License Application to convert the accelerated approval of Tivdak to full approval for recurrent or metastatic cervical cancer. The PDUFA action date is set for May 9.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:49 am

SPIR

Spire Global, Inc. (NYSE:SPIR) has announced a dedicated launch mission for NorthStar Earth & Space, with four satellites set to launch no earlier than January 18. The mission, named 'Four of a Kind', will be streamed live on YouTube from Rocket Lab Launch Complex 1 in New Zealand.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:48 am

BNTX

BioNTech presented its strategic priorities for 2024 at the J.P. Morgan Healthcare Conference, aiming to have ten or more registrational trials by the end of 2024 and to be commercial-ready by the end of 2025. The company reported an unaudited €17.5 billion in cash and equivalents for 2023 and anticipates revenues of about €3 billion for 2024.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:46 am

TFX

Teleflex announced the availability of its Titan SGS Stapler, designed for gastric tissue and sleeve pouch creation in bariatric procedures, now with staple line reinforcement. The product received FDA 510(k) clearance on October 6, 2023, and is currently available for pre-order.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:39 am